Sinopharm Group Co. Ltd. (SHTDF) reported earnings for nine months of RMB8.103 billion
The company's earnings totaled RMB8.103 billion, or RMB1.70 per share. This compares with RMB8.388 billion, or RMB1.69 per share, last year.
The company's revenue for the period fell 2.5% to RMB431.478 billion from RMB442.423 billion last year.
Sinopharm Group Co. Ltd. earnings at a glance (GAAP) :
-Earnings: RMB8.103 Bln. vs. RMB8.388 Bln. last year.-EPS: RMB1.70 vs. RMB1.69 last year.-Revenue: RMB431.478 Bln vs. RMB442.423 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.